search icon
search icon
Flag Arrow Down
Română
Română
Magyar
Magyar
English
English
Français
Français
Deutsch
Deutsch
Italiano
Italiano
Español
Español
Русский
Русский
日本語
日本語
中国人
中国人

Change Language

arrow down
  • Română
    Română
  • Magyar
    Magyar
  • English
    English
  • Français
    Français
  • Deutsch
    Deutsch
  • Italiano
    Italiano
  • Español
    Español
  • Русский
    Русский
  • 日本語
    日本語
  • 中国人
    中国人
Sections
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
About Us
Contact
Privacy policy
Terms and conditions
Quickly scroll through news digests and see how they are covered in different publications!
  • News
  • Exclusive
    • INSCOP Surveys
    • Podcast
    • EU
    • Diaspora
    • Republic of Moldova
    • Politics
    • Economy
    • Current Affairs
    • International
    • Sport
    • Health
    • Education
    • IT&C knowledge
    • Arts & Lifestyle
    • Opinions
    • Elections 2025
    • Environment
120 new news items in the last 24 hours
  1. Home
  2. International

King's College London has developed an experimental drug that improves the response of chemotherapy-resistant tumors by targeting a tumor defense protein.

Ana Maria Eftene
whatsapp
facebook
linkedin
x
copy-link copy-link
15 August 2025, 09:21
main event image
International
Foto: Pexels.com
google-preference

Always see our news on Google

The drug KCL-HO-1i developed by researchers at King's College London has the potential to transform treatments for chemotherapy-resistant cancers. It works by neutralizing the protein heme oxygenase-1 (HO-1), which helps tumors protect themselves from chemotherapy and immune system attacks. Preclinical tests have shown that the drug can make tumors more responsive to chemotherapy, even in previously resistant cases. Designed for oral administration, KCL-HO-1i could begin human clinical trials in two years, with the potential to expand its applications in oncology.

Sources

sursa imagine
Ziare.com
Speranță pentru bolnavii de cancer: Un nou medicament sporește eficacitatea chimioterapiei chiar și în cazul tumorilor rezistente
sursa imagine
Stiripesurse
A apărut pastila care dezarmează cancerul! Descoperirea care ar putea rescrie regulile chimioterapiei: Chiar și cele mai rezistente tumori răspund la tratament

Latest News

17:50

Intel intends to raise 15 billion dollars through stock sales to support the development of chip production

17:42

An ancient Roman shipwreck approximately 2,100 years old has been discovered off the coast of Sicily.

17:41

George Simion reacted after Nicușor Dan attacked the ANI law at the CCR: "He doesn't like transparency"

17:26

A strong earthquake of magnitude 6.6 occurred in Colombia. Casualties and significant damage have been reported.

17:25

CNIR conducts tests for the design of a section of the A8 Highway

See more news

NEWS ON THE SAME TOPICS

event image
Health
An experimental injection against cancer completely eliminated tumors in patients who did not respond to chemotherapy or immunotherapy.
event image
International
Major merger in British higher education: King's College London and Cranfield University will merge in 2027 to create a global institution.
event image
Health
WHO begins clinical study for an antiviral drug against Ebola
event image
Health
Cats could benefit from weight loss medications. The first tests are already underway.
event image
International
AstraZeneca announced the failure of a drug for a rare heart condition, causing a 9% drop in the company's shares.
event image
International
A girl died after an experimental treatment for Snijders Blok-Campeau syndrome, coordinated by researchers from a prestigious university in China. The parents paid 860,000 dollars for therapy.
app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview app preview
medically cancer chemotherapy

Editor’s Recommendations

main event image
Current Affairs
3 hours ago

SPECIAL Informat.ro / From "Black Volga" to TikTok. How an urban legend became a real risk in Romania

main event image
International
2 hours ago

The video cameras mounted on the British Navy drones were secretly transmitting information to China.

Sources
imagine sursa
imagine sursa
imagine sursa
imagine sursa
main event image
Exclusive
4 hours ago

SPECIAL Informat.ro / The top international political topics of the last week. Effects on Romania

main event image
Current Affairs
9 hours ago

The Ministry of Finance launches a new edition of TEZAUR / Non-taxable interest rates of up to 7.15% per year

Sources
imagine sursa
imagine sursa
imagine sursa
imagine sursa
main event image
Exclusive
4 hours ago
Original Content

EXCLUSIVE The top sports topics, in the last week

main event image
IT&C knowledge
4 hours ago

DOC/ The jellyfish that refuses to age and its lessons for regenerative medicine

app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview
app store badge google play badge
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
  • About Us
  • Contact
Privacy policy
Cookies Policy
Terms and conditions
Open source licenses
All rights reserved Strategic Media Team SRL

Technology in partnership with

anpc-sal anpc-sol